﻿<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<?xml-stylesheet type="text/xsl" href="/css/apdocuments/ap-case.xsl"?>
<apCase>
  <creationDate>2021-11-01</creationDate>
  <apCaseHeader>
    <fileNumbers>
      <fileNumber>3-20348</fileNumber>
    </fileNumbers>
    <respondents>
      <respondent>Rich Pharmaceuticals, Inc.</respondent>
    </respondents>
    <caseLink>/litigation/apdocuments/ap-3-20348.xml</caseLink>
  </apCaseHeader>
  <releaseItem>
    <date>2021-05-27</date>
    <releaseNumber>34-92047</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934</title>
    <secLink>/litigation/admin/2021/34-92047.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2021-06-11</date>
    <releaseNumber></releaseNumber>
    <otherReleaseNumbers />
    <title>Respondent's Initial Answer Order Instituting Administrative Proceedings and Notice of Hearing</title>
    <secLink>/litigation/apdocuments/3-20348-2021-06-11-respondent-initial-answer.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2021-10-04</date>
    <releaseNumber>34-93260</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Regarding Prehearing Conference</title>
    <secLink>/litigation/opinions/2021/34-93260.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2021-10-29</date>
    <releaseNumber>34-93470</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Making Findings and Revoking Registration of Securities Pursuant to Section 12(j) of the Securities Exchange Act of 1934 as to Rich Pharmaceuticals, Inc.</title>
    <secLink>/litigation/admin/2021/34-93470.pdf</secLink>
  </releaseItem>
</apCase>